sulpiride has been researched along with Anxiety Disorders in 16 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
Anxiety Disorders: Persistent and disabling ANXIETY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sulpiride and itopride are effective in the treatment of dyspepsia in the form of postprandial distress syndrome." | 9.19 | [Efficacy of sulpiride and itopride in the treatment of functional dyspepsia in women with emotional and eating disorders]. ( Chojnacki, C; Klupińska, G; Pawłowicz, M; Wachowska-Kelly, P; Walecka-Kapica, E; Wojtkiewicz, P, 2014) |
| "The efficacy of sulpiride in patients with anxiety disorders depending on the serum serotonin concentrations was evaluated." | 7.81 | [The efficacy of sulpiride in patients with anxiety disorders depending on the serum serotonin concentrations]. ( Kremenitskaya, SA; Solov'eva, NV; Vil'yanov, VB, 2015) |
| "The relationship between erectile dysfunction and sulpiride stimulatory effect on prolactin secretion was studied in 13 married male psychiatric outpatients." | 7.67 | Sulpiride-induced hyperprolactinemia and impotence in male psychiatric outpatients. ( Asher, I; Ben-David, M; Maoz, B; Treves, I; Weizman, A, 1985) |
| "Sulpiride is a substituted benzamide with selective dopaminergic blocking activity." | 5.31 | Gynecomastia with sulpiride. ( Fujii, A; Kaneda, Y, 2002) |
| "Sulpiride and itopride are effective in the treatment of dyspepsia in the form of postprandial distress syndrome." | 5.19 | [Efficacy of sulpiride and itopride in the treatment of functional dyspepsia in women with emotional and eating disorders]. ( Chojnacki, C; Klupińska, G; Pawłowicz, M; Wachowska-Kelly, P; Walecka-Kapica, E; Wojtkiewicz, P, 2014) |
| "The efficacy of sulpiride in patients with anxiety disorders depending on the serum serotonin concentrations was evaluated." | 3.81 | [The efficacy of sulpiride in patients with anxiety disorders depending on the serum serotonin concentrations]. ( Kremenitskaya, SA; Solov'eva, NV; Vil'yanov, VB, 2015) |
| "The aim of this study was to explore effects on anxiety-like behavior of the D2 dopamine receptor agonist, quinpirole and of the D2 dopamine receptor antagonist, sulpiride given alone or in combination with a low dose of 17β-estradiol (17β-E2) to ovariectomized (OVX) rats." | 3.79 | Anxiolytic-like effect of quinpirole in combination with a low dose of 17β-estradiol in ovariectomized rats. ( Fedotova, J, 2013) |
| "The relationship between erectile dysfunction and sulpiride stimulatory effect on prolactin secretion was studied in 13 married male psychiatric outpatients." | 3.67 | Sulpiride-induced hyperprolactinemia and impotence in male psychiatric outpatients. ( Asher, I; Ben-David, M; Maoz, B; Treves, I; Weizman, A, 1985) |
| "Patients with Tourette's syndrome often develop multiple psychopathological symptoms beyond the basic symptoms (motor and vocal tics)." | 1.31 | [Disguised Tourette's syndrome. A contribution to the differential diagnosis on phobia and fear]. ( Barnett, W; Bednarz, K; Haisch, S, 2002) |
| "Sulpiride is a substituted benzamide with selective dopaminergic blocking activity." | 1.31 | Gynecomastia with sulpiride. ( Fujii, A; Kaneda, Y, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (12.50) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Magdaleno-Madrigal, VM | 1 |
| Morales-Mulia, S | 1 |
| Nicolini, H | 1 |
| Genis-Mendoza, A | 1 |
| Cázares-Martínez Claudia, E | 1 |
| Pérez-Luna José, M | 1 |
| Morales-Mulia, M | 1 |
| Fedotova, J | 1 |
| Wachowska-Kelly, P | 1 |
| Walecka-Kapica, E | 1 |
| Wojtkiewicz, P | 1 |
| Pawłowicz, M | 1 |
| Klupińska, G | 1 |
| Chojnacki, C | 1 |
| Vil'yanov, VB | 1 |
| Kremenitskaya, SA | 1 |
| Solov'eva, NV | 1 |
| Ishola, IO | 1 |
| Awodele, O | 1 |
| Eluogu, CO | 1 |
| Hood, SD | 1 |
| Potokar, JP | 1 |
| Davies, SJ | 1 |
| Hince, DA | 1 |
| Morris, K | 1 |
| Seddon, KM | 1 |
| Nutt, DJ | 1 |
| Argyropoulos, SV | 1 |
| Ružić, K | 1 |
| Grahovac, T | 1 |
| Graovac, M | 1 |
| Dadić-Hero, E | 1 |
| Sepić-Grahovac, D | 1 |
| Sabljić, V | 1 |
| Englisch, S | 1 |
| Alm, B | 1 |
| Meyer-Lindenberg, A | 1 |
| Zink, M | 1 |
| Bell, C | 1 |
| Bhikha, S | 1 |
| Colhoun, H | 1 |
| Carter, F | 1 |
| Frampton, C | 1 |
| Porter, R | 1 |
| Bednarz, K | 1 |
| Haisch, S | 1 |
| Barnett, W | 1 |
| Mauri, M | 1 |
| Mancioli, A | 1 |
| Rebecchi, V | 1 |
| Corbetta, S | 1 |
| Colombo, C | 1 |
| Bono, G | 1 |
| Kato, K | 1 |
| Kaneda, Y | 1 |
| Fujii, A | 1 |
| Benazzi, F | 1 |
| Fava, GA | 1 |
| Grandi, S | 1 |
| Saviotti, FM | 1 |
| Conti, S | 1 |
| Bartolucci, G | 1 |
| Savron, G | 1 |
| Weizman, A | 1 |
| Maoz, B | 1 |
| Treves, I | 1 |
| Asher, I | 1 |
| Ben-David, M | 1 |
5 trials available for sulpiride and Anxiety Disorders
| Article | Year |
|---|---|
[Efficacy of sulpiride and itopride in the treatment of functional dyspepsia in women with emotional and eating disorders].
Topics: Aged; Anxiety Disorders; Benzamides; Benzyl Compounds; Depression; Dopamine Antagonists; Dyspepsia; | 2014 |
Dopaminergic challenges in social anxiety disorder: evidence for dopamine D3 desensitisation following successful treatment with serotonergic antidepressants.
Topics: Adult; Anxiety Disorders; Benzothiazoles; Cross-Over Studies; Diagnostic and Statistical Manual of M | 2010 |
The response to sulpiride in social anxiety disorder: D2 receptor function.
Topics: Adult; Affect; Antidepressive Agents; Anxiety Disorders; Cross-Over Studies; Dopamine Antagonists; D | 2013 |
Amisulpride in the treatment of behavioural disturbances among patients with moderate to severe Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Aggression; Alzheimer Disease; Amisulpride; Antipsychotic Agents; Anxiety D | 2006 |
Response of patients in mixed state of anxiety and depression to low dose sulpiride.
Topics: Adult; Anxiety Disorders; Depressive Disorder; Female; Humans; Male; Sulpiride | 1993 |
11 other studies available for sulpiride and Anxiety Disorders
| Article | Year |
|---|---|
Orexin-A promotes EEG changes but fails to induce anxiety in rats.
Topics: Animals; Anxiety; Anxiety Disorders; Arousal; Behavior, Animal; Dopamine D2 Receptor Antagonists; El | 2019 |
Anxiolytic-like effect of quinpirole in combination with a low dose of 17β-estradiol in ovariectomized rats.
Topics: Animals; Anxiety; Anxiety Disorders; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor A | 2013 |
[The efficacy of sulpiride in patients with anxiety disorders depending on the serum serotonin concentrations].
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Biomarkers; Drug Adm | 2015 |
Potentials of Mangifera indica in the treatment of depressive-anxiety disorders: possible mechanisms of action.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; Depression; Depress | 2016 |
Hyperprolactinaemia with amisulpride.
Topics: Amisulpride; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Anxiety Disorders; Bo | 2011 |
Pregabalin-associated increase of clozapine serum levels.
Topics: Antimanic Agents; Antipsychotic Agents; Anxiety Disorders; Clozapine; Female; gamma-Aminobutyric Aci | 2012 |
[Disguised Tourette's syndrome. A contribution to the differential diagnosis on phobia and fear].
Topics: Adult; Anxiety Disorders; Clomipramine; Clonazepam; Cognitive Behavioral Therapy; Combined Modality | 2002 |
Gynecomastia with sulpiride.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Anxiety Disorders; Estradiol; Gynecomastia; Human | 2002 |
Lorazepam, amitriptyline, and sulpiride: withdrawal effects.
Topics: Amitriptyline; Anxiety Disorders; Depressive Disorder; Drug Therapy, Combination; Female; Humans; Lo | 1991 |
Phenomenology and pathophysiology of antipsychotic withdrawal symptoms.
Topics: Adult; Agoraphobia; Anxiety Disorders; Depressive Disorder; Female; Humans; Middle Aged; Substance W | 1989 |
Sulpiride-induced hyperprolactinemia and impotence in male psychiatric outpatients.
Topics: Adult; Anxiety Disorders; Erectile Dysfunction; Humans; Male; Middle Aged; Prolactin; Schizophrenia; | 1985 |